Skip Navigation
Department of Health and Human Services
Slide Tray
0 slides

Return to Slide Library


Add Presentation to Slide Tray Presentation:

Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis

Slide: 44 of 46

Conclusions About Benefits and Adverse Effects of DMARDs (2 of 2)

Few studies of sufficient size make direct comparisons of DMARDs in well-characterized patient populations; thus, it is not clear in which circumstances one DMARD will yield better outcomes than another.

No one instrument for measuring disease activity or functional status has been identified as clearly superior.

Evidence about the rate, types, and severity of adverse effects is too limited to permit conclusions about risks.